Irinotecan (drug): clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

10

Conditions studied

12

US states with sites

2

Countries

Phase breakdown

Phase 1 1 Phase 2 2

Conditions being studied

Condition	Trials
BRAF V600 Colorectal Cancer	1
Colorectal cancer	1
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)	1
Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)	1
Large Cell Neuroendocrine Cancer (LCNEC)	1
Lung cancer	1
Neuroendocrine Carcinomas (NEC)	1
Neuroendocrine Prostate Cancer (NEPC)	1
Prostate cancer	1
Small Cell Lung Cancer (SCLC)	1

Recruiting trials involving Irinotecan (drug)

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
NCT07150247 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Irinotecan (drug)?

2 recruiting trials across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.